{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:08:16Z","timestamp":1791209296707,"version":"4.1.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2953,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1002\/hep.21664","type":"journal-article","created":{"date-parts":[[2007,7,24]],"date-time":"2007-07-24T23:16:31Z","timestamp":1185318991000},"page":"324-329","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":155,"title":["Oral IDN\u20106556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C\u2020"],"prefix":"10.1097","volume":"46","author":[{"given":"Paul J.","family":"Pockros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene R.","family":"Schiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell L.","family":"Shiffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"McHutchison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert G.","family":"Gish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nezam H.","family":"Afdhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manana","family":"Makhviladze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Huyghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Oltersdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20241201","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0092-8674(04)00046-7","article-title":"Cell death: critical control points","volume":"116","author":"Danial","year":"2004","journal-title":"Cell"},{"key":"R2-8-20241201","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1124\/jpet.103.062034","article-title":"Characterization of IDN\u20106556 (3\u2010[2\u2010(2\u2010tert\u2010butyl\u2010phenylaminooxalyl)\u2010 amino]\u2010propionylamino]\u20104\u2010oxo\u20105\u2010(2,3,5,6\u2010tetrafluoro\u2010phenoxy)\u2010pentanoic acid): a liver\u2010targeted caspase inhibitor","volume":"309","author":"Hoglen","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"R3-8-20241201","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1124\/jpet.103.060129","article-title":"The caspase inhibitor IDN\u20106556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse","volume":"308","author":"Canbay","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"R4-8-20241201","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/jlts.2003.50019","article-title":"The caspase inhibitor IDN\u20106556 prevents caspase activation and apoptosis in sinusoidal endothelial cells during liver preservation injury","volume":"9","author":"Natori","year":"2003","journal-title":"Liver Transpl"},{"key":"R5-8-20241201","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1053\/jhep.2001.28229","article-title":"Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection","volume":"34","author":"Bantel","year":"2001","journal-title":"HEPATOLOGY"},{"key":"R6-8-20241201","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1365-2893.2001.00316.x","article-title":"Fas\u2010mediated hepatocyte apoptosis is increased by hepatitis C virus infection and alcohol consumption, and may be associated with hepatic fibrosis: mechanisms of liver cell injury in chronic hepatitis C virus infection","volume":"8","author":"Pianko","year":"2001","journal-title":"J Viral Hepat"},{"key":"R7-8-20241201","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1055\/s-2007-1007150","article-title":"CD95\u2010induced apoptosis in human liver disease","volume":"18","author":"Galle","year":"1998","journal-title":"Semin Liver Dis"},{"key":"R8-8-20241201","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0016-5085(03)00907-7","article-title":"Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis","volume":"125","author":"Feldstein","year":"2003","journal-title":"Gastroenterology"},{"key":"R9-8-20241201","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0168-8278(00)00110-0","article-title":"Apoptosis in alcoholic hepatitis: a novel therapeutic target?","volume":"34","author":"Day","year":"2001","journal-title":"J Hepatol"},{"key":"R10-8-20241201","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0168-8278(00)00089-1","article-title":"Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis","volume":"34","author":"Natori","year":"2001","journal-title":"J Hepatol"},{"key":"R11-8-20241201","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1046\/j.1440-1746.2000.02083.x","article-title":"Alcohol consumption induces hepatocyte apoptosis in patients with chronic hepatitis C infection","volume":"15","author":"Pianko","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"key":"R12-8-20241201","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0168-8278(00)00047-7","article-title":"Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis","volume":"34","author":"Ziol","year":"2001","journal-title":"J Hepatol"},{"key":"R13-8-20241201","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1034\/j.1600-0676.2001.021004272.x","article-title":"Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis","volume":"21","author":"Fox","year":"2001","journal-title":"Liver"},{"key":"R14-8-20241201","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00007890-199907150-00018","article-title":"Apoptosis of sinusoidal endothelial cells occurs during liver preservation injury by a caspase\u2010dependent mechanism","volume":"68","author":"Natori","year":"1999","journal-title":"Transplantation"},{"key":"R15-8-20241201","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000049726","article-title":"Fas receptor is upregulated in livers from non\u2010heart\u2010beating donors","volume":"33","author":"Schnurr","year":"2001","journal-title":"Eur Surg Res"},{"key":"R16-8-20241201","doi-asserted-by":"crossref","first-page":"441","DOI":"10.5414\/CPP41441","article-title":"First clinical trial of a novel caspase inhibitor: anti\u2010apoptotic caspase inhibitor, IDN\u20106556, improves liver enzymes","volume":"41","author":"Valentino","year":"2003","journal-title":"Int J Clin Pharmacol Ther"},{"key":"R17-8-20241201","doi-asserted-by":"crossref","first-page":"49077","DOI":"10.1074\/jbc.M109791200","article-title":"Anti\u2010Fas induces hepatic chemokines and promotes inflammation by an NF\u2010kappa B\u2010independent, caspase\u20103\u2010dependent pathway","volume":"276","author":"Faouzi","year":"2001","journal-title":"J Biol Chem"},{"key":"R18-8-20241201","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.20051","article-title":"Apoptosis: the nexus of liver injury and fibrosis","volume":"39","author":"Canbay","year":"2004","journal-title":"HEPATOLOGY"},{"key":"R19-8-20241201","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2893.2005.00636.x","article-title":"Silymarin treatment of viral hepatitis: a systematic review","volume":"12","author":"Mayer","year":"2005","journal-title":"J Viral Hepat"},{"key":"R20-8-20241201","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hep.510260231","article-title":"Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C: a multicenter trial","volume":"26","author":"Bodenheimer","year":"1997","journal-title":"HEPATOLOGY"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.21664","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-200708000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T13:38:23Z","timestamp":1733060303000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-200708000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.21664","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}